Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sebatin is a proprietary, patent-pending botanical ingredient developed by Unigen, Inc. using its PhytoLogix® research platform. It consists of a synergistic blend of botanical extracts designed for applications in dietary supplements and skin care. Pre-clinical testing has demonstrated that Sebatin provides hepatoprotective effects, offering liver protection when administered both before and after induced liver damage. It is primarily marketed for detox support and liver health, though its specific botanical components and molecular mechanism of action remain proprietary. The product is intended for use in the dietary supplement and cosmeceutical industries rather than as a traditional pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sebatin.